Skip to content

Need to talk? Call or text 988 (US)

RecurrentDepression

Emotion recognition and genetic vulnerability to schizophrenia

David Mazoor, M.D.Published August 7, 20074 min read

Key points

  • A key component of social cognition, facial expression recognition, is one of the hallmark deficits of schizophrenia (Schneider et al, 2006).
  • Many of these regions, including the amygdala and the prefrontal and superior temporal cortices, are known to be reduced in volume in schizophrenia – see reviews by Lawrie & Abukmeil (1998) and Wong & Van Tol (2003) and the meta-analysis by Wright et al (2000).
  • Epidemiological studies of schizophrenia suggest that this disorder has a substantial genetic component.
  • Method Emotion and gender recognition were evaluated in a three-group pre – post study design in drugnaive patients with first-episode schizophrenia (n=40) and their unaffected siblings (n=30) compared with controls (n=26).

A key component of social cognition, facial expression recognition, is one of the hallmark deficits of schizophrenia (Schneider et al, 2006). Although people with schizophrenia may show deficits in other aspects of face perception (Hall et al, 2004), only expression recognition performance has been related to social dysfunction (Hooker & Park, 2002).

Studies have implicated interaction between the amygdala and prefrontal and temporal cortex in facial expression processing (Krolak-Salmon et al, 2004). In schizophrenia this deficit has been related to amygdala -hippocampal complex (AHC) dysfunction (Gur et al, 2002), although the frontal and temporal cortex may also have a role (Streit et al, 2001).

Many of these regions, including the amygdala and the prefrontal and superior temporal cortices, are known to be reduced in volume in schizophrenia – see reviews by Lawrie & Abukmeil (1998) and Wong & Van Tol (2003) and the meta-analysis by Wright et al (2000). Interestingly, despite a recent contradictory result (McDonald et al, 2006), reduced volume of the AHC has been consistently reported in healthy siblings of patients (Lawrie et al, 1999; Aleman & Kahn, 2005).

However, some methodological issues (inclusion criteria, regions of interest, medial temporal lobe considered as a whole) could account for these discrepancies. Moreover, siblings show poor perception of non-verbal social -emotional cues (Toomey et al, 1999). Facial expression recognition is one of the most crucial vectors of non-verbal communication relying on amygdala integrity and may therefore be impaired in healthy relatives of patients, although this has never been evidenced.

Epidemiological studies of schizophrenia suggest that this disorder has a substantial genetic component. Cognitive and social abilities, as well as the volumes of brain regions involved in emotion processing, have been found to be distributed along a continuum when comparing patients, siblings and controls, with siblings showing intermediate scores.

Aims To establish whether facial expression recognition is impaired in unaffected siblings of patients.

Method Emotion and gender recognition were evaluated in a three-group pre – post study design in drugnaive patients with first-episode schizophrenia (n=40) and their unaffected siblings (n=30) compared with controls (n=26).

Results Patients and their healthy siblings showed impaired emotion recognition but normal gender recognition compared with controls. Patients’performance did not improve despite effective clinical stabilisation.

Conclusions Impaired performance in healthy siblings and time stability in patients provides evidence of impairment of facial emotion recognition as an actual phenotype of schizophrenia.

BENOIT BEDIOU, PhD
University of Lyon, Centre Hospitalier Le Vinatier, Bron and Institut Fe’de’ratif des Neurosciences de Lyon, Bron, France

FATIMA ASRI, MD
University of Marrakech, Morocco

JEROME BRUNELIN, PhD
University of Lyon, Centre Hospitalier Le Vinatier and Institut Fe’de’ratif des Neurosciences de Lyon, Bron, France

PIERRE KROLAK-SALMON, MD, PhD
Institut National de la Sante’ et de la Recherche (INSERM) and Centre Hospitalier Le Vinatier, Bron

THIERRY D’AMATO, MD, PhD and MOHAMED SAOUD, MD, PhD
University of Lyon, Centre Hospitalier Le Vinatier and Institut Fe’de’ratif des Neurosciences de Lyon, Bron, France

BENOIT BEDIOU, PhD
University of Lyon, Centre Hospitalier Le Vinatier, Bron and Institut Fe’de’ratif des Neurosciences de Lyon, Bron, France

FATIMA ASRI, MD
University of Marrakech, Morocco

JEROME BRUNELIN, PhD
University of Lyon, Centre Hospitalier Le Vinatier and Institut Fe’de’ratif des Neurosciences de Lyon, Bron, France

PIERRE KROLAK-SALMON, MD, PhD
Institut National de la Sante’ et de la Recherche (INSERM) and Centre Hospitalier Le Vinatier, Bron

THIERRY D’AMATO, MD, PhD and MOHAMED SAOUD, MD, PhD
University of Lyon, Centre Hospitalier Le Vinatier and Institut Fe’de’ratif des Neurosciences de Lyon, Bron, France

IMANE TAZI, MD
University of Marrakech, Morocco

Correspondence: Dr Benoit Bediou,CH Le Vinatier,University of Lyon, EA 3092, 95 Boulevard Pinel, 69677 Bron Cedex, France. Email: benoit.bediou@ch-le-vinatier.fr

University of Marrakech, Morocco

Correspondence: Dr Benoit Bediou,CH Le Vinatier,University of Lyon, EA 3092, 95 Boulevard Pinel, 69677 Bron Cedex, France. Email: benoit.bediou@ch-le-vinatier.fr

Full article

Revised and edited by

David Mazoor, M.D.

Medically reviewedLast reviewed

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you are in crisis, call or text 988 (US) or your local emergency number.

If you need help now

Reaching out is a sign of strength.

If you are thinking about suicide or worried about someone, talk to someone today. In an emergency, call your local emergency number.